🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Happy Holidays from BARDA! We wish you all peace, joy, health, and happiness as we enter this holiday season, and into the new year!

There's still time to submit your abstract to DRIVe & CBRN’s ReDIRECT program! We seek to support the development of repurposed therapeutics to treat injuries caused by chemical threats. Submissions close March 31: ow.ly/aZR550Uk7qF

Join us at the Vaccine Innovation Forum during JPM Week in San Francisco on January 13, 2025! We will be showcasing technologies in vaccine development & announcing Concept Stage winners of the #PatchForwardPrize. Register: lu.ma/tlruy9x2

A new peer-reviewed study in The Lancet reveals that COVID-19 diagnostic test manufacturing, production, & distribution efforts saved 1.4 million lives & prevented 7 million hospitalizations. Find out more about these impacts & the study: aspr.hhs.gov/newsroom/Pages…

Decentralized clinical trials (DCTs) offer more convenient access for participants, which can speed enrollment, increase opportunities for data collection, and yield more representative results. Learn more: ow.ly/uoAb50Uz0Rc

There's still time to submit your abstract to our Influenza Vaccine Innovation program! We’re seeking to develop novel influenza #vaccines that can provide broader and longer-lasting protection against pandemic #flu. Submit by January 20, 2025: ow.ly/Y4Ls50UwYss

We are thrilled to announce the Concept Stage winners of the #PatchForwardPrize! Learn more about the winners and how the Patch Forward Prize is advancing microneedle patch-based RNA vaccines: ow.ly/yYWF50UFjYB #ProjectNextGen

There's still time to submit your abstract to DRIVe & CBRN’s ReDIRECT program! We seek to support the development of repurposed therapeutics to treat injuries caused by chemical threats. Submissions close March 31: ow.ly/aZR550Uk7qF

We’ve reopened our DRIVe & CBRN ReBooT EZ-BAA area of interest to support the development of repurposed & repositioned direct-acting or host-directed therapeutics to address filovirus (Ebola, Marburg, & Sudan virus) infections. Submission deadline is 4/30: ow.ly/26bk50UGs7Z

Through the RRPV | Rapid Response Partnership Vehicle, BARDA is partnering with Shionogi Inc. (U.S.) to advance a long-acting therapeutic aimed at preventing #COVID19 for people who are immune compromised. Learn more: ow.ly/m7yQ50UHSsY

We never stop working to protect the American people. Let’s take a brief look back at our work in 2024 to bolster preparedness for a range of potential health security threats. Learn more: ow.ly/BRwA50UI50y

This #MLKDay, honor Dr. King's legacy by serving your community. In the latest edition of the ASPR Blog, Medical Reserve Corps Deputy Director Spindel urges you to embrace the power of volunteering by joining the Medical Reserve Corps. bit.ly/42i8vNR #DayOfService #Volunteer

To help sustain a response-ready posture, we support & maintain a portfolio that helps provide long-term access to #MedicalCountermeasures. This approach bolsters national security & enhances preparedness: ow.ly/8FGh50UHRuu

Through RRPV | Rapid Response Partnership Vehicle, BARDA expands its partnership w/ mRNA vaccine developer Moderna to expand a rapid pandemic #influenza response capability. This effort aims to make safe & effective #vaccines available more quickly during influenza pandemics. ow.ly/Ep2M50UIPRm

Have you heard? We’re on the Bluesky bandwagon! Give us a follow at: ow.ly/yyx750UIQgL

We are partnering with globalsystemsengineering to enhance and modernize CHEMM, our digital resource designed for emergency responders & healthcare providers to access comprehensive information & guidance to aid in preparedness & response for chemical incidents: ow.ly/vkmJ50UIQNl

Tomorrow is the last day to submit your abstract to our Influenza Vaccine Innovation program! We’re seeking to develop novel influenza #vaccines that can provide broader and longer-lasting protection against pandemic #flu Submit by 12 pm ET on 1/20: sam.gov/opp/8f4d63db54…

Four BARDA-supported #MedicalCountermeasures have recently received U.S. FDA approval, licensure, or clearance. Learn more about these products and how BARDA helps enable their accessibility and availability during health security emergencies: medicalcountermeasures.gov/barda/fdaappro…